인쇄하기
취소

NHIC chief advocates "biosimilar forerunner

Published: 2010-05-12 06:59:00
Updated: 2010-05-12 06:59:00
National Health Insurance Corporation President Chung Hyung-keun said it will back the development of biosimilar products.

“We will continue to stand behind Korean drug makers to help them advance research and the development of biosimilar products,” Chung said in a seminar.

“We are willing to offer preferential prices over biosimilar products, once produced locally.”

Biosimilars are...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.